4//SEC Filing
Rhodes John B 4
Accession 0001615774-18-001748
CIK 0001430306other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 3:31 PM ET
Size
14.7 KB
Accession
0001615774-18-001748
Insider Transaction Report
Form 4
Rhodes John B
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2017-02-09−1,125→ 0 total→ Common Stock (750 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2017-05-27+1,125→ 15,970 total - Exercise/Conversion
Common Stock, $0.001 par value
2016-02-25+600→ 8,720 total - Exercise/Conversion
Restricted Stock Units
2016-02-25−600→ 0 total→ Common Stock (600 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2017-02-09+1,125→ 14,845 total - Exercise/Conversion
Restricted Stock Units
2017-05-27−1,125→ 0 total→ Common Stock (750 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On May 27, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date.
- [F3]On February 9, 2016, the reporting person was granted 750 restricted stock units, vesting in on the first anniversary of the grant date.
- [F4]On February 25, 2015, the reporting person was granted 600 restricted stock units, vesting in on the first anniversary of the grant date.
Documents
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001346251
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 3:31 PM ET
- Size
- 14.7 KB